These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22359493)

  • 1. DOGS: reaction-driven de novo design of bioactive compounds.
    Hartenfeller M; Zettl H; Walter M; Rupp M; Reisen F; Proschak E; Weggen S; Stark H; Schneider G
    PLoS Comput Biol; 2012; 8(2):e1002380. PubMed ID: 22359493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel histamine H4 and serotonin transporter ligands using the topological feature tree descriptor.
    Kiss R; Sándor M; Gere A; Schmidt E; Balogh GT; Kiss B; Molnár L; Lemmen C; Keseru GM
    J Chem Inf Model; 2012 Jan; 52(1):233-42. PubMed ID: 22168379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor.
    Tanrikulu Y; Proschak E; Werner T; Geppert T; Todoroff N; Klenner A; Kottke T; Sander K; Schneider E; Seifert R; Stark H; Clark T; Schneider G
    ChemMedChem; 2009 May; 4(5):820-7. PubMed ID: 19343764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaffold-hopping potential of fragment-based de novo design: the chances and limits of variation.
    Krueger BA; Dietrich A; Baringhaus KH; Schneider G
    Comb Chem High Throughput Screen; 2009 May; 12(4):383-96. PubMed ID: 19442066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concept of template-based de novo design from drug-derived molecular fragments and its application to TAR RNA.
    Schüller A; Suhartono M; Fechner U; Tanrikulu Y; Breitung S; Scheffer U; Göbel MW; Schneider G
    J Comput Aided Mol Des; 2008 Feb; 22(2):59-68. PubMed ID: 18064402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.
    Schneider G; Geppert T; Hartenfeller M; Reisen F; Klenner A; Reutlinger M; Hähnke V; Hiss JA; Zettl H; Keppner S; Spänkuch B; Schneider P
    Future Med Chem; 2011 Mar; 3(4):415-24. PubMed ID: 21452978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer design of bioactive molecules: a method for receptor-based de novo ligand design.
    Moon JB; Howe WJ
    Proteins; 1991; 11(4):314-28. PubMed ID: 1758885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand based design of novel histamine H₄ receptor antagonists; fragment optimization and analysis of binding kinetics.
    Smits RA; Lim HD; van der Meer T; Kuhne S; Bessembinder K; Zuiderveld OP; Wijtmans M; de Esch IJ; Leurs R
    Bioorg Med Chem Lett; 2012 Jan; 22(1):461-7. PubMed ID: 22153663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in de novo design and scaffold hopping.
    Mauser H; Guba W
    Curr Opin Drug Discov Devel; 2008 May; 11(3):365-74. PubMed ID: 18428090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lead identification and optimization of diaminopyrimidines as histamine H4 receptor ligands.
    Sander K; Kottke T; Proschak E; Tanrikulu Y; Schneider EH; Seifert R; Schneider G; Stark H
    Inflamm Res; 2010 Mar; 59 Suppl 2():S249-51. PubMed ID: 20012148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flux (1): a virtual synthesis scheme for fragment-based de novo design.
    Fechner U; Schneider G
    J Chem Inf Model; 2006; 46(2):699-707. PubMed ID: 16563000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beam Search for Automated Design and Scoring of Novel ROR Ligands with Machine Intelligence*.
    Moret M; Helmstädter M; Grisoni F; Schneider G; Merk D
    Angew Chem Int Ed Engl; 2021 Aug; 60(35):19477-19482. PubMed ID: 34165856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular determinants of selective agonist and antagonist binding to the histamine H₄ receptor.
    Istyastono EP; de Graaf C; de Esch IJ; Leurs R
    Curr Top Med Chem; 2011; 11(6):661-79. PubMed ID: 21261593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo design - hop(p)ing against hope.
    Schneider G
    Drug Discov Today Technol; 2013 Dec; 10(4):e453-60. PubMed ID: 24451634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffold hopping in de novo design. Ligand generation in the absence of receptor information.
    Lloyd DG; Buenemann CL; Todorov NP; Manallack DT; Dean PM
    J Med Chem; 2004 Jan; 47(3):493-6. PubMed ID: 14736231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98(3.36) of the human histamine H₄ receptor.
    Nijmeijer S; Engelhardt H; Schultes S; van de Stolpe AC; Lusink V; de Graaf C; Wijtmans M; Haaksma EE; de Esch IJ; Stachurski K; Vischer HF; Leurs R
    Br J Pharmacol; 2013 Sep; 170(1):89-100. PubMed ID: 23347159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flux (2): comparison of molecular mutation and crossover operators for ligand-based de novo design.
    Fechner U; Schneider G
    J Chem Inf Model; 2007; 47(2):656-67. PubMed ID: 17315990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand identification for G-protein-coupled receptors: a lead generation perspective.
    Bleicher KH; Green LG; Martin RE; Rogers-Evans M
    Curr Opin Chem Biol; 2004 Jun; 8(3):287-96. PubMed ID: 15183327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of nanomolar ligands with novel scaffolds for the histamine H4 receptor by virtual screening.
    Levoin N; Labeeuw O; Billot X; Calmels T; Danvy D; Krief S; Berrebi-Bertrand I; Lecomte JM; Schwartz JC; Capet M
    Eur J Med Chem; 2017 Jan; 125():565-572. PubMed ID: 27718472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation mechanism of the human histamine H4 receptor--an explicit membrane molecular dynamics simulation study.
    Jójárt B; Kiss R; Viskolcz B; Keseru GM
    J Chem Inf Model; 2008 Jun; 48(6):1199-210. PubMed ID: 18572901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.